Medarex #39;s Hodgkin #39;s treatment gets orphan status PRINCETON, NJ (Dow Jones/AP) _ Biopharmaceutical company Medarex Inc. said Wednesday its Hodgkin #39;s disease treatment was granted orphan drug designation by the Food and Drug Administration.